Clinical Trial Update: A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine [Phase 1, Phase 2]

View source ↗

Summary

This update summarizes a Phase 1/2 trial of an adjuvanted inactivated H7N9 influenza vaccine conducted by Shanghai Institute Of Biological Products, which has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• H7n9 Influenza

Drugs mentioned

• Adjuvanted inactivated H7N9 influenza vaccine (adjuvanted inactivated H7N9 influenza vaccine)

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: H7N9 Influenza | Phase 1, Phase 2 | Status: COMPLETED